Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Explore practical ways to improve your business plan for selling, making it more appealing to potential buyers and investors.
24,642 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Wheels Up Experience is in the spotlight as its stock faces a sharp decline. This article breaks down the primary cau...
A fresh take on a notable portfolio move: Kettle Hill Capital reveals a sizable Braze stake via a 747,715-share initi...
Nvidia still dominates AI hardware, but the stock's sparkle has cooled. This article breaks down the three big reason...
When americans cutting back spending becomes the backdrop, investors wonder where growth still hides. This article br...
Turn a single property into a multi-tenant assisted living setup. Discover practical steps to make more money with th...
Retirees rely on COLA to keep up with rising prices. This piece explains why social security's 2027 cola might be lar...
As Medicare IRMAA surcharges loom, retirees face higher taxes on RMDs and reduced spendable cash. This report explain...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Tesla's robotaxi just launched in Miami, signaling a new era for the company’s autonomous ride-hailing push. This art...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...